Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maintaining Skeletal Health in Postmenopausal Women With Surgically Resected Stage I-IIIa Hormone-receptor Positive Breast Cancer Who Are Receiving Anastrozole, Through the Use of Alendronate as Determined by the Osteoporosis Australia Bone Maintenance Algorithm

NCT00122356 is registered in ClinicalTrials.gov with Barwon Health as lead sponsor.

NCT NCT00122356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00122356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maintaining Skeletal Health in Postmenopausal Women With Surgically Resected Stage I-IIIa Hormone-receptor Positive Breast Cancer Who Are Receiving Anastrozole, Through the Use of Alendronate as Determined by the Osteoporosis Australia Bone Maintenance Algorithm
Lead sponsor
Barwon Health
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2005
Completion date
March 31, 2013
Enrollment
303 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer